Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8

general

Stage IIIA includes: T0-2, N1, M0. T0: No evidence of primary tumor. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)

6

Centers

16

Active Trials

—

Cancer Funding

Specific Cancer Types(1)

NameCenters
Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v86

Top Centers for Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8(6)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
High-Volume Research Center
73.3
2
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
High-Volume Research Center
73.3
3
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
Active Research Program
50.8
4
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
Active Research Program
50.8
5
University of Illinois Cancer CenterChicago, IL
Active Research Program
50.8
6
Boston University Cancer CenterBoston, MA
Active Research Program
50.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →